October 10th, 2012
Barrett esophagus with high-grade dysplasia: How should it be staged?
I am amazed at the variation I have seen in the use of endoscopic ultrasound (EUS) in staging Barrett esophagus (BE). Some of us use EUS universally, and others (myself included) never use it to stage intramucosal carcinoma or high-grade dysplasia.
So, let me propose a case and ask what you would do: The patient is a healthy 58-year-old man with 3 cm of BE with a 0.5 cm nodule in the distal segment. There is no ulceration or other surface irregularity found upon inspection with high-definition white-light and narrow-band imaging.
Would you:
1) Stage with EUS and resect the nodule?
2) Resect the nodule and stage with EUS only if intramucosal carcinoma or greater neoplasia is seen?
3) Resect the nodule and stage with EUS for invasive adenocarcinoma only?
4) Perform radiofrequency ablation (RFA) of the nodule after staging EUS?
5) Perform RFA of the nodule without staging EUS?
I look forward to your comments.
Categories: Endoscopy, Patient care, Uncategorized
Tags: Barrett esophagus
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
8 Responses to “Barrett esophagus with high-grade dysplasia: How should it be staged?”

M. Brian Fennerty, MD
Founding Editor
NEJM Journal Watch Gastroenterology
Learn more about Gut Check on Gastroenterology.
Search the Archive
Archives by Date
From NEJM: Recently in Gastroenterology- Operative versus Nonoperative Management for Appendicitis July 2, 2026This feature about treatment of appendicitis offers a case vignette accompanied by two essays, one recommending operative management and the other supporting a nonoperative approach.
- Artificial Intelligence and Detection of Hirschsprung Disease July 2, 2026This artificial intelligence–derived and validated machine-learning system appeared to predict the risk of Hirschsprung disease with the use of genetic and demographic data from participants in China.
- A Major Step toward a Cure for Hepatitis B Infection June 25, 2026The current treatment of chronic hepatitis B infection includes nucleoside or nucleotide analogue (NA) therapy and pegylated interferon. Both of these treatments are effective in suppressing hepatitis B virus (HBV) replication and in reducing the risk of cirrhosis and hepatocellular carcinoma.1 However, these treatments do not eradicate HBV,...
- Prevention and Treatment of Peanut Allergy June 25, 2026Peanuts should be introduced at 4 to 6 months of age in infants at high risk for allergy and at approximately 6 months of age in other infants. For infants with peanut allergy, early immunotherapy is safer and more effective.
- Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection June 25, 2026In two phase 3 trials, 19% of patients with chronic hepatitis B infection had a functional cure with the antisense oligonucleotide bepirovirsen, 24 weeks after stopping all HBV treatment; functional cure was not seen with placebo.
- Operative versus Nonoperative Management for Appendicitis July 2, 2026
-
Tag Cloud
- Ambulatory endoscopy center antiretroviral therapy Barrett esophagus boceprevir bowel preparation CMS colitis colonoscopy colorectal cancer screening CT colonography DDW drug interactions efavirenz endoscopist Endoscopy gastroenterology GI bleeding hepatitis HIV IBS Irritable Bowel Syndrome Medicare midazolam nurse Plavix PPIs primary care probiotics ritonavir Screening colonoscopy sedation sigmoidoscopy telaprevir training virtual colonoscopy

I perform EUS and would feel much safer staging with EUS first then performing EMR.
perfom RF abalation of nodule after EUS
I WILL RESECT THE NODULE AND STAGE WITH EUS ONLY IF INTRAMUCOSAL CARCINOMA OR GREATER NEOPLASIA IS SEEN
Option 3
Resect with EMR, and then only EUS if you are staging an invasive cancer. EUS often over- or under-stages mucosal lesions.
Dear Dr. Fennerty,
we perform EUS prior to resection only if a higher degree of invasive carcinoma is suspected. If not, I would rather go ahead with your second option to resect the nodule endoscopically and apply EUS later on only if a submucosal carcinoma or greater neoplasia is seen.
Best regards.
Stephan
Resect the nodule and stage with EUS only if intramucosal carcinoma or greater neoplasia is seen
I had exactly the patient you described 1 yea ago.
patient with barret’s of 2-3 cm. that was on surveillance for years. a nodule of 0,5 cm. appeared that was adenocarcinoma: I send him for EUS–> resection of the nodule–> and RFA OF THE BARRETT’S. until now he is o’kay. his age about 60 and very fat: high operation risk.